FIELD: medicine, veterinary science. SUBSTANCE: invention relates to anthelmintic agent comprising of albendazol and copper complex as an active substance that is enclosed in microcapsules making of acetylcellulose in the ratio of albendazole, copper sulfate and acetylcellulose = 1:1:0.5, respectively. Insertion of albendazole metal complex in anthelmintic agent composite allows to enhance therapeutic activity and inclusion of albendazole metal complex in microcapsule made of acetylcellulose provides the prolonged end effect that is necessary for radical chemotherapy of larval echinococcosis. Agent provides the complete inhibition of growth of exhinococcus larvocysts and death of all population of parasite. EFFECT: enhanced effectiveness of agent. 1 cl, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTHELMINTHIC AGENT | 1998 |
|
RU2153329C2 |
| METHOD FOR OBTAINING DIAGNOSTIC ANTIGEN IN CESTODES | 2002 |
|
RU2219551C1 |
| METHOD OF IMMUNOTHERAPY FOR SECONDARY ALVEOLAR ECHINOCOCCOSIS | 2017 |
|
RU2674767C1 |
| METHOD FOR MODELING IMAGINAL ALVEOCOCCOSIS | 2006 |
|
RU2310923C1 |
| METHOD OF TREATMENT LARVAL ECHINOCOCCOSIS OF LABORATORY ANIMALS | 2013 |
|
RU2517044C1 |
| METHOD FOR PREVENTING SECONDARY ALVEOLAR ECHINOCOCCOSIS (HYDATIDOSIS) | 2004 |
|
RU2279274C2 |
| AGENT FOR INHIBITION OF LARVAL ECHINOCOCCUS DEVELOPMENT IN ANIMALS | 0 |
|
SU1813442A1 |
| METHOD FOR PREVENTION OF LARVAL STAGE OF ECHINOCOCCOSIS ALVEOLARIS | 2016 |
|
RU2609858C1 |
| ADJUVANT COMPOSITION FOR INJECTION TISSUE HELMINTHIASIS VACCINES | 2007 |
|
RU2348427C2 |
| MEDICINAL AGENT BASED ON SYNTHETIC COPOLYMER OF VINYLPYRIDINE ROW FOR TREATING TISSUE HELMINTHIASIS | 2019 |
|
RU2727935C1 |
